Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedThink is a specialized healthcare communications agency that provides strategic medical and marketing services to the pharmaceutical, biotechnology, and medical device industries. The company operates through two primary divisions: MedThink SciCom, which focuses on scientific communications and medical affairs, and MedThink Communications, which specializes in healthcare advertising and brand strategy. Their expertise lies in translating complex clinical data into actionable insights and compelling narratives for healthcare providers and patients. In early 2022, MedThink was acquired by Fingerpaint, a prominent independent healthcare marketing firm, to enhance its scientific depth and medical communications offerings. Headquartered in Raleigh, North Carolina, the firm continues to support global life science clients across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedThink.